Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn22resultaten gevonden
Farmaco-epidemiologie

Novel methodologies for causal research with real world data

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Ali Alghamdi
  • Promoters E. Hak
  • Co-Promoters M.J. Bijlsma
  • Jaar 2022-2026
Farmaco-epidemiologie

Towards personalized primary prevention of cerebroand cardiovascular diseases: observational studies based on the real-world data of 167,000 participants in the Netherlands

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Xuechun Li
  • Promoters E. Hak
  • Co-Promoters S. Mubarik
  • Jaar 2021-2025
Farmaco-epidemiologie

RCT or RWE? Investigating standards that RWE needs to meet to supplement evidence from RCTs - building a framework

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Stefan Verweij
  • Promoters E. Hak P.G.M. Mol
  • Co-Promoters M.J. Bijlsma K. Oude Rengerink
  • Jaar 2022-2027
Farmaco-economie

Quality of life, frailty assessment, and pharmacoeconomics in the age of targeted therapies for acute myeloid leukemia

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Benno Diekmann
  • Promoters E.N. van Roon
  • Co-Promoters M. Hoogendoorn N.J.G.M. Veeger
  • Jaar 2022-2026
Farmaco-epidemiologie

Estimating the scale of immunity gaps towards Measles and Rubella elimination: Case studies and epidemiological profile of Nigeria

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus A.E. Jean Baptiste
  • Promoters E. Hak E.A. Sanders
  • Co-Promoters S.J.M. Hahne
  • Jaar 2019-2022
Medicatiebeoordeling

Effects of communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication: a cluster-randomized trial in primary care (CO-DEPRESCRIBE)

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Peter Stuijt
  • Promoters Petra Denig Katja Taxis
  • Jaar 2022-2026
Farmaco-economie

Optimization of the evaluation of oncology drugs for reimbursement

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Sharon Wolters
  • Promoters M. Postma F.G.A. Jansman
  • Jaar 2019-2025

The research focusses on several aspects related to reimbursement: factors influencing the time to reimbursement, measures to improve the time to reimbursement, differences in the clinical evidentiary requirements of oncology assessment, EMA versus HTA bodies and changes in economic evaluations of oncology drugs in time.
 

Pagina 1 van 4